Free Trial

Judges Scientific (LON:JDG) Stock Crosses Below 200-Day Moving Average - What's Next?

Judges Scientific logo with Computer and Technology background

Key Points

  • Judges Scientific's stock price has fallen below its **200-day moving average**, trading at GBX 6,300 compared to the average of GBX 7,309.98.
  • Wall Street analysts have given a **consensus rating of "Buy"** for Judges Scientific, with a price target of GBX 7,900 despite recent price declines.
  • Recent insider activity shows significant investment, with insiders purchasing a total of **548 shares** valued at over $3.6 million in the last ninety days.
  • Interested in Judges Scientific? Here are five stocks we like better.

Shares of Judges Scientific plc (LON:JDG - Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 7,309.98 ($99.78) and traded as low as GBX 6,200 ($84.63). Judges Scientific shares last traded at GBX 6,300 ($86.00), with a volume of 7,109 shares.

Analyst Ratings Changes

A number of brokerages recently issued reports on JDG. Shore Capital reissued a "house stock" rating on shares of Judges Scientific in a report on Thursday, July 24th. Berenberg Bank reaffirmed a "buy" rating and set a GBX 7,900 price target on shares of Judges Scientific in a research note on Thursday, September 11th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, Judges Scientific has a consensus rating of "Buy" and an average price target of GBX 7,900.

Check Out Our Latest Stock Analysis on JDG

Judges Scientific Stock Up 1.7%

The company has a current ratio of 1.97, a quick ratio of 0.65 and a debt-to-equity ratio of 70.79. The firm has a market capitalization of £409.74 million, a price-to-earnings ratio of 3,996.43, a PEG ratio of 0.56 and a beta of 0.83. The stock has a fifty day moving average of GBX 6,706.52 and a 200-day moving average of GBX 7,250.05.

Insider Buying and Selling

In related news, insider Ian Wilcock bought 6 shares of the firm's stock in a transaction that occurred on Tuesday, August 5th. The shares were acquired at an average cost of GBX 6,188 per share, for a total transaction of £371.28. Also, insider David Cicurel sold 315 shares of Judges Scientific stock in a transaction on Tuesday, July 29th. The stock was sold at an average price of GBX 6,400, for a total value of £20,160. Insiders have purchased 548 shares of company stock worth $3,617,776 in the last three months. 10.83% of the stock is currently owned by insiders.

About Judges Scientific

(Get Free Report)

Judges Scientific plc AIM: JDG, is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005. The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities.

See Also

Should You Invest $1,000 in Judges Scientific Right Now?

Before you consider Judges Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Judges Scientific wasn't on the list.

While Judges Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.